BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23391110)

  • 1. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging.
    Klimstra DS
    Semin Oncol; 2013 Feb; 40(1):23-36. PubMed ID: 23391110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.
    Klimstra DS; Modlin IR; Adsay NV; Chetty R; Deshpande V; Gönen M; Jensen RT; Kidd M; Kulke MH; Lloyd RV; Moran C; Moss SF; Oberg K; O'Toole D; Rindi G; Robert ME; Suster S; Tang LH; Tzen CY; Washington MK; Wiedenmann B; Yao J
    Am J Surg Pathol; 2010 Mar; 34(3):300-13. PubMed ID: 20118772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.
    Klimstra DS; Modlin IR; Coppola D; Lloyd RV; Suster S
    Pancreas; 2010 Aug; 39(6):707-12. PubMed ID: 20664470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
    Ardill JE; O'Dorisio TM
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.
    Rindi G; Klöppel G; Alhman H; Caplin M; Couvelard A; de Herder WW; Erikssson B; Falchetti A; Falconi M; Komminoth P; Körner M; Lopes JM; McNicol AM; Nilsson O; Perren A; Scarpa A; Scoazec JY; Wiedenmann B; ;
    Virchows Arch; 2006 Oct; 449(4):395-401. PubMed ID: 16967267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current knowledge on diagnosis and staging of neuroendocrine tumors.
    Oberg K; Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():3-7. PubMed ID: 21311954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
    Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
    Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
    Kim JY; Hong SM
    Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine tumors of the luminal gastrointestinal tract.
    Grin A; Streutker CJ
    Arch Pathol Lab Med; 2015 Jun; 139(6):750-6. PubMed ID: 26030244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches.
    Oberg K
    Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
    Strosberg JR; Weber JM; Feldman M; Coppola D; Meredith K; Kvols LK
    J Clin Oncol; 2013 Feb; 31(4):420-5. PubMed ID: 23248248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices.
    Remes SM; Tuominen VJ; Helin H; Isola J; Arola J
    Am J Surg Pathol; 2012 Sep; 36(9):1359-63. PubMed ID: 22895268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
    Anlauf M
    Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroenteropancreatic neuroendocrine neoplasms: historical context and current issues.
    Yang Z; Tang LH; Klimstra DS
    Semin Diagn Pathol; 2013 Aug; 30(3):186-96. PubMed ID: 24144288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNM: evolution and relation to other prognostic factors.
    Sobin LH
    Semin Surg Oncol; 2003; 21(1):3-7. PubMed ID: 12923909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The terminology, classifications and staging of neuroendocrine tumors of the pancreas].
    Kubyshkin VA; Kochatkov AV; Konstantinova MM; Kriger AG
    Khirurgiia (Mosk); 2012; (6):4-8. PubMed ID: 22951606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].
    Klöppel G
    Pathologe; 2015 May; 36(3):237-45. PubMed ID: 25947223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
    Goldin SB; Aston J; Wahi MM
    Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome.
    Jann H; Roll S; Couvelard A; Hentic O; Pavel M; Müller-Nordhorn J; Koch M; Röcken C; Rindi G; Ruszniewski P; Wiedenmann B; Pape UF
    Cancer; 2011 Aug; 117(15):3332-41. PubMed ID: 21246527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.